{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:55:31Z","timestamp":1783652131229,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.dld.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T22:42:08Z","timestamp":1475188928000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Beta blockers and cirrhosis, 2016"],"prefix":"10.1016","volume":"49","author":[{"given":"Mattias","family":"Mandorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2016.09.013_bib0005","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2016.09.013_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to beta-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00508-012-0190-5","article-title":"Noninvasive screening for liver fibrosis and portal hypertension by transient elastography\u2014a large single center experience","volume":"124","author":"Reiberger","year":"2012","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1016\/j.dld.2016.09.013_bib0020","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","article-title":"U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients","volume":"64","author":"Tripathi","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0025","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28575","article-title":"Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites","author":"Kalambokis","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis","volume":"127","author":"Merkel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-012-9353-8","article-title":"Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial","volume":"7","author":"Sarin","year":"2013","journal-title":"Hepatology International"},{"key":"10.1016\/j.dld.2016.09.013_bib0050","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3748\/wjg.v21.i10.3100","article-title":"Nonselective beta-blockers in cirrhotic patients with no or small varices: a meta-analysis","volume":"21","author":"Qi","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension","volume":"11","author":"Cal\u00e8s","year":"1999","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-311735","article-title":"Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial","author":"Bhardwaj","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-312814","article-title":"Prevention of progression from small to large varices: are we there yet? An updated meta-anaylsis","author":"Mandorfer","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0070","first-page":"CD004544","article-title":"Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults","author":"Gluud","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.dld.2016.09.013_bib0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2036.2012.05074.x","article-title":"Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices","volume":"35","author":"Thiele","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2016.09.013_bib0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/liv.12452","article-title":"Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review","volume":"34","author":"Puente","year":"2014","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0090","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/gutjnl-2012-304182","article-title":"Carvedilol: the beta-blocker of choice for portal hypertension?","volume":"62","author":"Bosch","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2016.09.013_bib0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/hep.23045","article-title":"Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed","volume":"50","author":"Tripathi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2013.11.019","article-title":"Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial","volume":"60","author":"Shah","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0110","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0115","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","article-title":"Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding","volume":"27","author":"Lo","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0120","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","article-title":"Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding","volume":"61","author":"Stanley","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0125","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2016.327","article-title":"A randomized, multi-center, open-label study to evaluate the efficacy of carvedilol vs. propranolol to reduce portal pressure in patients with liver cirrhosis","author":"Kim","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2016.09.013_bib0130","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.28352","article-title":"Non-selective beta-blockers do not affect mortality in cirrhosis patients with ascites: post hoc analysis of three RCTs with 1198 patients","volume":"63","author":"Bossen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.1840360612","article-title":"Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Banares","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0140","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1478-3231.2009.02038.x","article-title":"Beta-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis","volume":"29","author":"Senzolo","year":"2009","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0150","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ajg.2011.456","article-title":"Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers","volume":"107","author":"Hernandez-Gea","year":"2012","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0155","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers","volume":"36","author":"Bang","year":"2016","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0160","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/liv.13147","article-title":"Nonselective beta blockers in patients with ascites: implications of a nationwide study","volume":"36","author":"Mandorfer","year":"2016","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0170","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/liv.12782","article-title":"Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials","volume":"35","author":"Thiele","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1940-6207.CAPR-11-0450","article-title":"Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis","volume":"5","author":"Nkontchou","year":"2012","journal-title":"Cancer Prevention Research"},{"key":"10.1016\/j.dld.2016.09.013_bib0180","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/MEG.0000000000000677","article-title":"The use of beta-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis","volume":"28","author":"Herrera","year":"2016","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.mehy.2013.08.026","article-title":"Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis","volume":"81","author":"Thiele","year":"2013","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.dld.2016.09.013_bib0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach","volume":"19","author":"D\u2019Amico","year":"1999","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.dld.2016.09.013_bib0195","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0200","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","article-title":"Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis","volume":"346","author":"Feu","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2016.09.013_bib0205","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gut.2008.171207","article-title":"Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial","volume":"58","author":"Garcia-Pagan","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension","volume":"51","author":"La Mura","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cld.2014.07.002","article-title":"Measurement of portal pressure","volume":"18","author":"Abraldes","year":"2014","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/j.dld.2016.09.013_bib0220","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/liv.12522","article-title":"A prospective observational study on tolerance and satisfaction to hepatic haemodynamic procedures","volume":"35","author":"Casu","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0225","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/liv.12783","article-title":"Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient","volume":"35","author":"Ferlitsch","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00535-011-0517-4","article-title":"Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis","volume":"47","author":"Reiberger","year":"2012","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0240","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2016.01.022","article-title":"Assessment of response to beta-blockers by expression of betaArr2 and RhoA\/ROCK2 in antrum mucosa in cirrhotic patients","volume":"64","author":"Trebicka","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0245","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0168-8278(15)30088-X","article-title":"O074: a metabolomic study of serum from patients with cirrhosis identifies 2 metabolites that accurately predict the acute HVPG response to \u03b2-blocker therapy","volume":"62","author":"Reverter","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0250","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0255","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2011.01.034","article-title":"Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study","volume":"55","author":"Serste","year":"2011","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0260","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0270","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0275","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/gutjnl-2016-312129","article-title":"Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters","volume":"65","author":"Njei","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0280","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0285","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1053\/j.gastro.2014.08.030","article-title":"Reply: to PMID 24631577","volume":"147","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.09.013_bib0290","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/jgh.13002","article-title":"Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: a retrospective cohort study","volume":"30","author":"Bucsics","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0295","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13160","article-title":"The trigger matters\u2014outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites","author":"Bucsics","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2016.09.013_bib0300","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2011.04.033","article-title":"Betablockers induce cardiac chronotropic incompetence","volume":"56","author":"Krag","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0168-8278(91)90807-N","article-title":"Propranolol and haemodynamic response in cirrhosis","volume":"13","author":"Bendtsen","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0310","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gutjnl-2016-311573","article-title":"Lack of consensus for usage of beta-blockers in end-stage liver disease","volume":"65","author":"Thorhauge","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.09.013_bib0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0325","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/liv.12786","article-title":"The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis","volume":"35","author":"Serste","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.09.013_bib0330","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(15)00309-8","article-title":"Acute-on-chronic liver failure","volume":"386","author":"Bernal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2016.09.013_bib0335","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0340","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198112033052302","article-title":"Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study","volume":"305","author":"Lebrec","year":"1981","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2016.09.013_bib0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.1840060119","article-title":"Short-term effects of propranolol on portal venous pressure","volume":"6","author":"Garcia-Tsao","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0350","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/S0168-8278(16)00314-7","article-title":"THU-347 progressive alterations in systemic and cadiopulmonary hemodynamics occur in patients with cirrhosis and predict death in decompensated cirrhosis","volume":"64","author":"Turco","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.09.013_bib0355","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865816307435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865816307435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T22:20:47Z","timestamp":1536358847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865816307435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1590865816307435"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2016.09.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta blockers and cirrhosis, 2016","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}